Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
13. January 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8759
Articles 1 - 20 / 175177
Prostate cancer with incidental thoracic splenosis: a diagnostic challenge unveiled by 18Â F-PSMA PET/CT imaging.
J Cardiothorac Surg
Vlaes B, Smets D, Corveleyn H, De Pauw V.
PMID: 41527001 [PubMed - as supplied by publisher]
Comparative analysis of EAU, AUA, and NCCN guidelines for the management of non-muscle invasive bladder cancer.
BMC Urol
Ayd, Aykaç A, Kaya C, Sungur M.
PMID: 41526868 [PubMed - as supplied by publisher]
Adaptive ensemble learning for prostate cancer classification on multi-modal MRI: reducing unnecessary biopsies.
BMC Med Imaging
Aymaz S, O, Aymaz , Ayd, Okatan AE, Kad, Bulut E.
PMID: 41526840 [PubMed - as supplied by publisher]
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer.
World J Urol
Régnier S, Gabriel PE, Ouzaid I, Moschini M, Soria F, D'Andrea D, Shariat SF, Budowski A, Poyet C, Roumiguie M, Maestro MÁ, Briganti A, Krajewski W, Hendricksen K, Veerman H, Afferi L, Mattei A, Di Bona C, Zamboni S, Simeone C, Thenault R, Verhoest G, Gontero P, Xylinas E.
PMID: 41526608 [PubMed - indexed for MEDLINE]
Immune-modulating medications: the masquerading culprit of epididymo-orchitis.
BMJ Case Rep
Buchinsky DS, Polenakovik HM, Hakim JI.
PMID: 41526075 [PubMed - indexed for MEDLINE]
CBCT-based Online Adaptive Radiotherapy for Prostate Cancer: Dosimetrical Aspects and Comparison to Non-Adaptive Conventional IGRT.
Technol Cancer Res Treat
Scheele NC, Fischer J, Hampe L, Niemeier T, Moldauer J, Schmitt D, Guhlich M, Leu M, Dröge LH, Strauß A, Rieken S, Fischer LA, El Shafie RA.
PMID: 41525208 [PubMed - indexed for MEDLINE]
A REtrospective Study to Describe the Real-World Treatment Landscape in Patients with Metastatic Castration-Resistant PROstate Cancer: REMPRO.
Adv Ther
Manneh R, Hashem T, Young JJ, Joshi A, Bahadir S, Omar A, Eid S, Elsayes A, Gonzalez F, Elsayed M, Kantharaju P.
PMID: 41525044 [PubMed - as supplied by publisher]
Targeting the PI3K/AKT/mTOR signaling pathway in prostate cancer: Molecular dysregulation, therapeutic advances, and future directions.
Saudi Pharm J
Alobid S.
PMID: 41525007 [PubMed]
A Longitudinal Study on Development and Validation of the Prostate Cancer Scale Among the System of Quality of Life Instruments for Patients with Cancer (QLICP-PR V2.0) Based on Classical Test Theory and Generalizability Theory.
Ann Surg Oncol
Wei W, Guo F, Zhang T, Chen Y, Li G, Luo J, Wan C.
PMID: 41524879 [PubMed - as supplied by publisher]
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-NaĂŻve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.
Prostate
Mizokami A, Matsumoto R, Miyake H, Uemura H, Uemura H, Kawakami S, Nakamura K, Shigekatsu Maekawa, Tsuchiya H, Okazaki S, Adachi E, Yano R, Tajima Y, Fujimoto K, Matsuyama H.
PMID: 41524484 [PubMed - as supplied by publisher]
Avoiding unnecessary biopsy in suspicious prostate cancer using PRIMARY score ≤3 and PSAD ≤0.2 ng/mL/cm3: a real-world, dual-center study from China.
Int J Surg
He J, Qi L, Chen M, Hu S, Gao X, Tang Y, Chen S, Cai Y.
PMID: 41524086 [PubMed - as supplied by publisher]
Outcomes of Free Flap Surgery in Head and Neck Cancer Patients With Chronic Kidney Disease: A Single-Institution Retrospective Study of 61 Cases.
Cureus
Nagano K, Osaki M, Kuba K, Hatanaka A, Hara M, Manaka K, Kinoshita S, Mitsumura K, Mukae R, Ohtake E.
PMID: 41523460 [PubMed]
Focal irreversible electroporation for the treatment of localised prostate cancer: a systematic review.
Transl Androl Urol
Cheng J, Adhami M, King D, Yaxley J, Kavnoudias H, Grummet J.
PMID: 41522319 [PubMed]
Immunohistochemical study of Rho-kinase pathway expression in a mouse model of prostate hypertrophy for preliminary study of progressive prostate cancer model establishment.
Transl Androl Urol
Yang YM, Kitagawa K, Hirata Y, Moriwaki M, Ono T, Chiang YT, Chen KC, Shigemura K.
PMID: 41522316 [PubMed]
Knowledge, attitudes, and practices regarding prostate cancer and early screening among middle-aged and elderly Chinese men: a cross-sectional study.
Transl Androl Urol
Tang S, Wang J, Xu J, Shen J.
PMID: 41522314 [PubMed]
Diagnostic performance of gastrin-releasing peptide receptor-targeted positron-emission tomography in biochemically recurrent prostate cancer-a systematic review and meta-analysis.
Quant Imaging Med Surg
Huang H, Huang Y, Xie Z, Tian R, Shen G.
PMID: 41522030 [PubMed]
Retrospective Analysis of Vesicourethral-Anastomosis Stricture/Urethral Stricture After Robotic-Assisted Laparoscopic Radical Prostatectomy With and Without Radiotherapy.
Int J Urol
Massouh K, Leucht K, Leistritz L, Grimm MO.
PMID: 41521473 [PubMed - indexed for MEDLINE]
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study.
World J Urol
Scilipoti P, Zaurito P, Longoni M, Tremolada G, Cosenza A, , Gabriel PE, Dutto D, Katzendorn O, Krajewski W, Laukhtina E, Oberneder K, Elena JLR, Aranda J, Puentedura AL, Velasco JC, Contieri R, Hurle R, Subiela JD, Fernández A, Marcq G, Szostek A, Mastroianni R, Simone G, Pichler R, Álvarez-Maestro M, Bazán AA, Klatte T, du Biest AM, Ferrando V, Buisan O, López AV, Zazzara M, Ludovico GM, Carando R, Radziszewski P, Soria F, Pradere B, D'Andrea D, Shariat SF, Montorsi F, Salonia A, Briganti A, Gontero P, Xylinas E, Moschini M, European Association of Urology -Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group, EuroGemDoce Study Group Collaborators.
PMID: 41521375 [PubMed - in process]
Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer.
Cancer Med
Faraj KS, Oerline M, Kaufman SR, Dall C, Srivastava A, Liu X, Caram MEV, Shahinian VB, Hollenbeck BK.
PMID: 41521275 [PubMed - indexed for MEDLINE]
Theranostic Nanoparticles in Prostate Cancer: Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites.
Cancer Med
Uti DE, Omang WA, Alum EU, Bawa I, Ugwu OP, Idowu AO, Atangwho IJ, Egbung GE.
PMID: 41521160 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 175177
Page 1 of 8759
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy